Barclays Q2 Preview on salesforce.com (CRM): So Far, So Good

Barclays maintains an 'Overweight' on salesforce.com (NYSE: CRM) price target of $169.00.

Analyst, Raimo Lenschow, said, "We are fairly in line with consensus for Q2 with billings, deferred revenue and subscription revenue all looking somewhat sub-seasonal with the Q3 forecast looking more in-line for billings but still sub-seasonal on revenue. We also find that the Number of Transactions grew c. 60% y/y against tough comps, which is fine, although reiterate our view that it is unclear how useful a read this is for billings growth."

CRM reports Q2 on August 23, 2012.

For an analyst ratings summary and ratings history on salesforce.com click here. For more ratings news on salesforce.com click here.

Shares of salesforce.com closed at $139.84 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
• APEI to build AI student platform with Salesforce starting in 2027
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'